In CGGA data shown in Fig. 1c, the SGO2 mRNA expression level was significantly higher in WHO grade IV (n = 218) than in grade III gliomas (n = 115; p = 0.014) and in grade II gliomas (n = 124; p = 2.92 × 10−13). Here, SGO2 is linked to central nervous system cancer.